Antisense compounds targeted to connexins and methods of use thereof

Details for Australian Patent Application No. 2011200868 (hide)

Owner Coda Therapeutics (NZ) Ltd

Inventors Laux, Wilda; Green, Colin R.

Agent Spruson & Ferguson

Pub. Number AU-A-2011200868

Parent 2004294824

Filing date 28 February 2011

Wipo publication date 17 March 2011

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

17 March 2011 Application Open to Public Inspection

  Published as AU-A-2011200868

17 March 2011 Complete Application Filed

16 February 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Laux-Fenton, Wilda and Green, Colin R.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011200869-System and method for improved treatment of sleeping disorders using therapeutic positive airway pressure

2011200867-Method for producing hydrophobically modified acrylic rheology modifiers